Skip to main content
. 2017 Sep 28;9(9):350–358. doi: 10.4329/wjr.v9.i9.350

Figure 5.

Figure 5

Flowchart showing clinical outcomes in patients with elevated prostatic 18F-labelled fluorodeoxyglucose uptake.